Health and Medical News Germany's Merck KGaA said Monday it struck an alliance over cancer immunotherapy drugs with Pfizer, triggering an upfront payment of $850 million by the U.S. drugmaker.
by via @ Health and Medical News
by via @ Health and Medical News